Thailand Approves Third Covid-19 Vaccine for Emergency Use from Johnson & Johnson

The Food and Drug Administration on March 25, 2021, granted the emergency use authorization for Johnson & Johnson Covid-19 vaccine, making it the third vaccine to be approved for use in Thailand.

 

J&J’s vaccine showed 86% efficacy against severe forms of Covid-19 in the United States, and 82% against severe variants in South Africa.

More importantly, J&J’s vaccine requires only one dose, making logistics much easier as well as more convenient for the patients.